vs
Side-by-side financial comparison of Evercore Inc. (EVR) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Evercore Inc. is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× SELECT MEDICAL HOLDINGS CORP). Evercore Inc. runs the higher net margin — 23.0% vs 1.4%, a 21.6% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (100.3% vs 6.4%). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (42.2% CAGR vs 2.8%).
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
EVR vs SEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $322.7M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | — | 4.6% |
| Net Margin | 23.0% | 1.4% |
| Revenue YoY | 100.3% | 6.4% |
| Net Profit YoY | 106.1% | 225.7% |
| EPS (diluted) | $7.20 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $838.0M | $1.3B | ||
| Q1 25 | $699.0M | $1.4B | ||
| Q4 24 | $979.5M | $1.3B | ||
| Q3 24 | $738.4M | $1.3B | ||
| Q2 24 | $693.4M | $1.3B |
| Q1 26 | $322.7M | — | ||
| Q4 25 | $204.0M | $20.2M | ||
| Q3 25 | $144.6M | $28.8M | ||
| Q2 25 | $97.2M | $40.6M | ||
| Q1 25 | $146.2M | $56.7M | ||
| Q4 24 | $140.4M | $-16.1M | ||
| Q3 24 | $78.4M | $55.6M | ||
| Q2 24 | $73.8M | $77.6M |
| Q1 26 | — | — | ||
| Q4 25 | 24.2% | 4.6% | ||
| Q3 25 | 20.8% | 5.4% | ||
| Q2 25 | 18.0% | 6.5% | ||
| Q1 25 | 16.0% | 8.3% | ||
| Q4 24 | 21.8% | 1.6% | ||
| Q3 24 | 16.7% | 4.3% | ||
| Q2 24 | 15.9% | 5.8% |
| Q1 26 | 23.0% | — | ||
| Q4 25 | 15.7% | 1.4% | ||
| Q3 25 | 13.8% | 2.1% | ||
| Q2 25 | 11.6% | 3.0% | ||
| Q1 25 | 20.9% | 4.2% | ||
| Q4 24 | 14.3% | -1.2% | ||
| Q3 24 | 10.6% | 4.4% | ||
| Q2 24 | 10.6% | 6.1% |
| Q1 26 | $7.20 | — | ||
| Q4 25 | $4.80 | $0.17 | ||
| Q3 25 | $3.41 | $0.23 | ||
| Q2 25 | $2.36 | $0.32 | ||
| Q1 25 | $3.48 | $0.44 | ||
| Q4 24 | $3.32 | $-0.12 | ||
| Q3 24 | $1.86 | $0.43 | ||
| Q2 24 | $1.81 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $26.5M |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | — | $1.7B |
| Total Assets | — | $5.9B |
| Debt / EquityLower = less leverage | — | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $26.5M | ||
| Q3 25 | $2.4B | $60.1M | ||
| Q2 25 | $1.7B | $52.3M | ||
| Q1 25 | $1.4B | $53.2M | ||
| Q4 24 | $2.4B | $59.7M | ||
| Q3 24 | $1.8B | $191.5M | ||
| Q2 24 | $1.7B | $111.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $1.8B | $1.7B | ||
| Q2 25 | $1.7B | $1.7B | ||
| Q1 25 | $1.5B | $1.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.9B | ||
| Q2 24 | $1.5B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | $5.4B | $5.9B | ||
| Q3 25 | $4.4B | $5.7B | ||
| Q2 25 | $3.7B | $5.7B | ||
| Q1 25 | $3.3B | $5.7B | ||
| Q4 24 | $4.2B | $5.6B | ||
| Q3 24 | $3.6B | $8.0B | ||
| Q2 24 | $3.3B | $7.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $64.3M |
| Free Cash FlowOCF − Capex | — | $5.2M |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $807.5M | $64.3M | ||
| Q3 25 | $560.9M | $175.3M | ||
| Q2 25 | $437.7M | $110.3M | ||
| Q1 25 | $-549.7M | $-3.5M | ||
| Q4 24 | $686.4M | $125.4M | ||
| Q3 24 | $234.5M | $181.0M | ||
| Q2 24 | $348.5M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $798.6M | $5.2M | ||
| Q3 25 | $541.5M | $122.2M | ||
| Q2 25 | $411.7M | $45.6M | ||
| Q1 25 | $-569.3M | $-55.8M | ||
| Q4 24 | $673.1M | $62.0M | ||
| Q3 24 | $226.6M | $130.3M | ||
| Q2 24 | $340.7M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 61.6% | 0.4% | ||
| Q3 25 | 51.8% | 9.0% | ||
| Q2 25 | 49.1% | 3.4% | ||
| Q1 25 | -81.4% | -4.1% | ||
| Q4 24 | 68.7% | 4.7% | ||
| Q3 24 | 30.7% | 10.2% | ||
| Q2 24 | 49.1% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 4.2% | ||
| Q3 25 | 1.9% | 3.9% | ||
| Q2 25 | 3.1% | 4.8% | ||
| Q1 25 | 2.8% | 3.9% | ||
| Q4 24 | 1.4% | 4.8% | ||
| Q3 24 | 1.1% | 4.0% | ||
| Q2 24 | 1.1% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.96× | 3.19× | ||
| Q3 25 | 3.88× | 6.09× | ||
| Q2 25 | 4.50× | 2.72× | ||
| Q1 25 | -3.76× | -0.06× | ||
| Q4 24 | 4.89× | — | ||
| Q3 24 | 2.99× | 3.25× | ||
| Q2 24 | 4.72× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVR
| Advisory Fees (1) | $1.2B | 89% |
| Commissions and Related Revenue | $62.7M | 4% |
| Underwriting Fees | $55.1M | 4% |
| Asset Management and Administration Fees (2) | $23.7M | 2% |
| Other Revenue, net | $15.4M | 1% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
